October 6, 2016
aTyr Pharma, a company engaged in the discovery and development of therapeutics to address severe rare diseases, is currently conducting two trials of Resolaris (ATYR1940) in patients with rare myopathies with an immune component.
Join our Circle of Friends
Receive updates about our research and events
For payment by check, please make out to "Friends of FSH Research" and send to
We are a designated 501(c)(3) non-profit organization, thus all of your donations are fully tax-deductible.